Haopeng Sun

机构：China Pharmaceutical University

发表论文 4 篇 · 总被引 3 次 · h-index 1

代表论文

• Discovery of Highly Selective AKR1C3 Inhibitors to Overcome EGFR C797S-Mediated Osimertinib Resistance in Non-Small Cell Lung Cancer (2026 · Journal of Medicinal Chemistry · 被引 2)
• Sculpting Cell Fate: The Expanding Universe of Nondegradative Proximity‐Inducing Tools (2026 · ChemMedChem · 被引 1)
• Development of tacrine-based multitarget-directed ligands as dual AChE/EGFR inhibitors with neuroprotective activity (2026 · Bioorganic & Medicinal Chemistry)
• 2‐(Diphenylphosphinoyl)acetyl Group Enabled Divergent Synthesis of 2′‐ O ‐Acetyl Phenylethanoid Glycosides (2026 · Chemistry - A European Journal)